Looking for Wegovy at a Reduced Price? Here's How UK Pricing Actually Works

Does Wegovy actually go on sale or get reduced for private patients in the UK?

A question our prescribers hear most weeks: is there a cheaper time to start, a code to use, or a deal to wait for? The honest answer is no, not through legitimate channels. Wegovy is a Prescription-Only Medicine regulated under the Human Medicines Regulations 2012, and UK law prohibits advertising it with price incentives in the way a retailer might promote a product. What does change, legitimately, is the underlying cost structure in the market.

Novo Nordisk has made pricing commitments in certain territories, and UK private providers operate against a backdrop of wholesale costs, dispensing overheads and mandatory clinical infrastructure. How Wegovy is priced for private patients reflects all of those layers, not just the manufacturer's ex-works figure. If you see a provider advertising Wegovy at a price that looks dramatically lower than the market, that gap is almost always explained by something missing from the service (the clinical review, the prescription fee, the aftercare) or by supply that has not come through the licensed UK chain.

The MHRA has issued clear public warnings about counterfeit weight-loss medicines sold online, including fake pens seized in quantities running to roughly 20 million doses with an estimated street value of around £45 million. A price that looks too good is worth treating as a red flag, not a bargain, and you can read more about what legitimate Wegovy price reductions actually look like before drawing any conclusions about a low headline figure. You can report a suspect seller at the MHRA's Yellow Card scheme.

What does a legitimate Wegovy price in the UK typically include, and what might it leave out?

Private Wegovy pricing varies by provider and by dose. Since Eli Lilly's widely reported list-price changes to Mounjaro in late 2025 shifted the GLP-1 market, semaglutide pricing has attracted renewed attention too. Reported private Wegovy prices across providers have typically ranged from roughly £149 to £375 per month depending on the dose and what is bundled in, these figures are hedged estimates drawn from market reporting, not guarantees of what any individual will pay.

The dose matters because the titration schedule for Wegovy runs from 0.25mg up to 2.4mg weekly, and with the MHRA's April 2026 approval of a dedicated 7.2mg single-dose pen, the upper end of the maintenance range has expanded further. What the 1mg dose costs is a different figure from the 2.4mg or 7.2mg maintenance dose, and providers price each tier separately. If a headline figure does not specify which dose it covers, ask.

Beyond the per-dose cost, look carefully at what the headline number excludes. Some providers charge separately for the initial consultation, the prescription itself, delivery, and any follow-up reviews, costs that can add £20–£80 or more per month on top of the advertised pen price. A full breakdown of Wegovy's cost components is worth reading before comparing quotes side by side.

Where does nume sit on Wegovy pricing, and why isn't it the cheapest?

We entered this market knowing we would not win a race to the bottom on price, and we are comfortable with that. Our position is one transparent figure that covers everything: the consultation, the Independent Prescriber's review, the prescription, the medicine dispensed from our GPhC-registered pharmacy (registration 9012878), free next-working-day DPD delivery in unbranded packaging, and priority access to clinical aftercare seven days a week. Nothing is stripped out to hit a lower headline number.

There are no discount codes, voucher schemes or promotional windows at nume. Offering price incentives on a prescription medicine would be at odds with how we think responsible dispensing should work. What you get instead is a prescriber who actually reads your answers (not software routing you to a formulaic outcome) and a clinical re-review every time you need a repeat, with no automatic renewal. Our approach to clinical oversight is the part of the cost that does not show up in a price comparison table.

Current treatment pricing is listed on our treatment page, clearly, without small print. If you want to understand exactly what is included before you start, that is the right place to look.

Is cheapest the right question to ask about a prescription weight-loss medicine?

For most purchases, the lowest price for the same product is the right answer. Prescription medicines are a different situation. Two Wegovy pens are not interchangeable if one came through the licensed UK supply chain and one did not. Provenance, cold-chain integrity and the clinical supervision wrapped around the medicine are not optional extras, they are what makes the treatment safe to use.

NICE's appraisal of semaglutide for weight management, published as TA875, sets out the clinical framework within which this medicine is meant to be used: appropriate patient selection, monitoring and review. Stripped-back services that compete on price alone typically compromise one or more of those elements. The saving on a single pen is rarely worth the risk of inadequate clinical oversight or, worse, a medicine that is not what the label says it is.

If the cost of private treatment is a genuine barrier, it is worth understanding the full Wegovy picture, including NHS eligibility routes, before deciding. And if you are ready to explore whether treatment is right for you, the sensible next step is a proper conversation with a prescriber, not a search for a code that shaves ten pounds off a pen.